Addiction Audio

In this episode, Dr Tsen Vei Lim talks to Dr Amelie Zacher and Professor Boris B Quednow. Amelie is a postdoctoral researcher and Boris is a professor, both from the Department of Adult Psychiatry, University Hospital of Psychiatry Zurich, University of Zurich, Switzerland. The interview covers Amelie and Boris’s research article on drug-related intrusive memories in cocaine use disorder.What is an addiction memory? [01:20]Examples of addiction memories intruding on those with cocaine use intrusions [02:45]The emotions with reliving addiction memories [04:40]The practical importance of characterising intrusions in cocaine use disorder [06:09]How Amelie and Boris measured the intrusions [08:28]The key findings from the study [09:44]Existing treatments that already target intrusive memories [12:15]What is memory reconsolidation? [15:31]How far are we from implementing treatment of intrusive memories in clinical practice? [17:22]About Tsen Vei Lim: Tsen Vei is an academic fellow supported by the Society for the Study of Addiction, currently based at the Department of Psychiatry at the University of Cambridge. His research integrates computational modelling, experimental psychology, and neuroimaging to understand the neuropsychological basis of addictive behaviours. He holds a PhD in Psychiatry from the University of Cambridge and a BSc in Psychology from the University of Bath in the UK. About Amelie Zacher: Amelie is a postdoctoral researcher in Professor Boris B Quednow’s lab for Experimental Pharmacopsychology and Psychological Addiction Research at the University Hospital of Psychiatry Zurich and the University of Zurich, Switzerland. Her research focuses on the intersection of addiction, trauma, and memory, particularly intrusive memories and their relationship with craving and emotional distress. Using ecological momentary assessment and experimental approaches, she investigates shared and distinct mechanisms underlying intrusive memories in cocaine use disorder and posttraumatic stress disorder, as well as the potential of memory reconsolidation-based interventions to modify these memories.About Boris B Quednow: Boris studied psychology at the University of Bonn, Germany, and obtained his PhD in neuroscience from Ruhr University Bochum, Germany. He is currently Full Professor of Experimental Pharmacopsychology and Psychological Addiction Research at the Department of Adult Psychiatry, University Hospital of Psychiatry Zurich, University of Zurich, Switzerland. His research focuses on understanding the neuropsychopharmacological mechanisms underlying alterations in social and non-social cognition and decision-making, impulsivity, and reward processing associated with recreational substance use and substance use disorders.Tsen Vei, Amelie and Boris have no conflicts of interest to declare.Original article: Substance-related intrusive memories in cocaine use disorder are different from but associated with craving https://doi.org/10.1111/add.70449The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.Music provided by Jack Shakespeare. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr Elle Wadsworth talks to Dr Julie Brummer, an Assistant Professor at the Centre for Alcohol and Drug Research at Aarhus University in Denmark. The interview covers Julie’s article on drug use disorders among people convicted of large-, moderate- and small-scale drug supply crimes in Denmark.A background on the relationship between drug use and drug supply [00:55]The motivation to examine drug use disorders among people convicted of drug supply crimes [02:45]The methods used in the study [05:15]The key findings on the prevalence of drug use disorders [08:31]The key findings on the group characteristics of drug use history among those convicted of a serious drug crime [10:01]The implications of the findings on drug treatment [11:21]The interpretation of ‘fringe’ players [12:06]Drug treatment in prisons [13:22]The take home messages [14:09]The next steps for Julie’s group with this dataset [14:45]The replicability of this study in other jurisdictions [16:10]About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health. Elle holds a voluntary role at The Loop, a non-profit service provider of drug checking in the UK. About Julie Elizabeth Brummer: Julie is an assistant professor at the Centre for Alcohol and Drug Research, Aarhus University, Denmark. She is an editor of Drugs: Education, Prevention and Policy and an associate editor of Nordic Studies on Alcohol and Drugs. She was a consultant for the World Health Organization Regional Office for Europe’s Alcohol and Illicit Drugs and Health in Prisons Programmes from 2011 to 2018. Her current research focuses on trajectories into serious drug crime, alcohol’s harms to others, adolescent heavy drinking, young people in treatment for opioid use disorders, and register-based methods.Declarations of interest: None Original article: Drug use disorders among people convicted of large-, moderate- and small-scale drug supply crimes: A register-based retrospective comparative study https://doi.org/10.1111/add.70612 The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr Elle Wadsworth talks to Rose Laing, a PhD candidate at the Monash Addiction Research Centre in Melbourne, Australia. The interview covers Rose’s article on psychosocial health and hazardous alcohol use among 50- to 70-year-olds in south-east Melbourne, Australia.Psychosocial health and the motivation to look at the relationship between psychosocial health and alcohol use [01:00]Why 50–70-year-olds are an important population for studying this topic [03:03]The methods used in the study [03:43]What is Latent Profile Analysis [04:50]The four profiles found in the Latent Profile Analysis [06:24]Socialising and drinking alcohol at the time of retirement [07:42]The key findings in terms of alcohol use outcomes [08:12]Rose’s interpretation of the ‘socially connected poor mental health’ group having the greatest probability of hazardous use [09:15]What we can do with Rose’s findings [10:56]The take home messages [12:40]The next steps for the Beyond 50 study [14:02]About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health. Elle holds a voluntary role at The Loop, a non-profit service provider of drug checking in the UK. About Rose Laing: Rose is a researcher and PhD candidate at the Monash Addiction Research Centre at Monash University in Melbourne, Australia. Her work focuses on the intersection of population health, ageing and substance use. Her PhD program of work centres on the Beyond 50 cohort study, which is investigating how physical and mental health, social wellbeing, and substance use in adults aged 50 to 70 years can impact individuals’ ability to age healthily. Rose's thesis is investigating the relationship between social isolation, loneliness and alcohol use within this cohort.Declarations of interest: None Original article: Psychosocial health and hazardous alcohol use among 50- to 70-year-olds: A cross-sectional latent profile analysis in south-east Melbourne, Australia https://doi.org/10.1111/add.70603The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr Tsen Vei Lim talks to Dr Janaka Kosgolla and Professor Doug Smith. Janaka is an assistant research scientist and Doug is a professor, both from the School of Social Work at the University of Illinois Urbana-Champaign in the United States. The interview covers Janaka and Doug’s research article on joint associations of recovery capital and polygenic risk with electronic health record observed remission and relapse in drug use disorder.What is recovery capital? [01:36]Examples of recovery capital [02:32]What are polygenic risk scores? [03:30]What motivated Janaka and Doug to explore the relationship between recovery capital and polygenic risk scores [07:32]How Janaka and Doug addressed their research question [08:50]The key findings from the study [10:24]Do recovery capital and polygenic risk scores interact with each other? [11:59]Do people with greater genetic risk require more recovery capital? [14:17]Whether we have data on what type of treatment the participants received [15:20]The exploration of mental health within the relationship [16:38]The findings in the context of treatment and policy [18:03]About Tsen Vei Lim: Tsen Vei is an academic fellow supported by the Society for the Study of Addiction, currently based at the Department of Psychiatry at the University of Cambridge. His research integrates computational modelling, experimental psychology, and neuroimaging to understand the neuropsychological basis of addictive behaviours. He holds a PhD in Psychiatry from the University of Cambridge and a BSc in Psychology from the University of Bath in the UK. About Janaka Kosgolla: Janaka is an assistant research scientist at the Center for Prevention Research and Development (CPRD) in the School of Social Work at the University of Illinois Urbana-Champaign. His research focuses on adolescent substance use behaviour and recovery, as well as recovery from substance use disorders among adults. He examines how recovery capital, genetic susceptibility, and community resources relate to remission and recovery. He also works on several Medicaid projects, providing SQL programming support.About Doug Smith: Doug has served on the faculty of the School of Social Work since 2008. His research focuses on substance use disorder (SUD) treatment outcomes, especially among adolescents and emerging adults. The National Institutes of Health (NIH), Substance Abuse and Mental Health Services Administration (SAMHSA), the United States Department of Justice (DOJ), private donations, and internal sources have funded his work. He currently directs the Center for Prevention Research and Development (CPRD) inside the School of Social Work. CPRD has an annual budget of $3.5 million dollars and employs approximately 30 staff members. His recent work focuses on adolescents in recovery. His books include Emerging Adults in Substance Use Disorder Treatment (Oxford) and Motivational Interviewing with Families (Guilford).Tsen Vei, Janaka and Doug have no conflicts of interest to declare.Original article: Joint associations of recovery capital and polygenic risk with electronic health record observed remission and relapse in substance use disorder: Longitudinal evidence from the All of Us research program https://doi.org/10.1111/add.70582The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.Music provided by Jack Shakespeare. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr Annika Theodoulou speaks to Dr Yang-Chieh Brian Chen, a psychiatric resident at the University of Texas Health Science Center in Houston, US. The interview covers Brian’s research article on all-cause and cause-specific mortality in gambling disorder using evidence from a nation-wide matched and sibling cohort study in Taiwan.A background on gambling disorder [01:09]All-cause and cause-specific mortality in gambling disorder [02:59]Why Brian focused on the relationship between gambling disorder and quality of life and suicidal ideation [04:11]The value of looking at accidental death and natural causes [06:00]The difference between results in European populations compared to the Taiwanese population [07:38]The study design that Brian used for the study [08:58]The importance of controlling for demographic and clinical factors [11:21]A summary of the mortality risk associated with gambling disorder [12:26]How we can generalize the findings [13:24]Brian’s take home messages [15:01]The implications of the findings for clinicians [17:14]A singular message on gambling disorder for the listeners [17:47]About Annika Theodoulou: Annika is a Research Fellow at the National Centre for Education and Training on Addiction at Flinders University, South Australia. Her work focuses on health behaviours, including smoking cessation and weight management, with an emphasis on evidence synthesis. She completed a Doctor of Philosophy in Primary Health Care at the University of Oxford, where her research examined socioeconomic inequalities in smoking cessation behaviours and outcomes using quantitative and qualitative methods. Her doctoral research was funded by the Society for the Study of Addiction (SSA) and The Rotary Foundation. Annika is an Associate Editor of Nicotine & Tobacco Research and holds a Bachelor of Health Sciences and a Master of Clinical Science from the University of Adelaide.About Yang-Chieh Brian Chen: Brian is currently a psychiatry resident in the psychiatry residency program at the University of Texas Health Science Center at Houston. He graduated from China Medical University in Taichung, Taiwan, and completed two years of postgraduate training at Kaohsiung Chang Gung Memorial Hospital. He has worked with his research mentor, psychiatrist Dr. Chih-Wei Hsu, on several projects focused on database research. He is devoted to research in psychiatry with the goal of making advancements toward improved treatment options in mental health. His current research interests include interventional psychiatry and neurocircuitry. Original article: All-cause and cause-specific mortality in gambling disorder: Evidence from a nation-wide matched and sibling cohort study in Taiwan https://doi.org/10.1111/add.70397The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.Music by Jack Shakespeare. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr Elle Wadsworth talks to Dr Abi Stevely, a Research Fellow at the Sheffield Addictions Research Group in the UK. The interview covers Abi’s article on the price of alcohol-free and low-alcohol drinks compared to regular-strength drinks using sales data in Great Britain.The term ‘No/lo’ refers to alcohol free (No) and low alcohol (Lo) drinks. What are alcohol-free and low alcohol drinks? [01:00]The use of ‘no/lo’ to refer to alcohol-free and low alcohol drinks [01:38]The main consumers of alcohol-free and low alcohol products in the UK [02:02]The motivation to explore the costs of alcohol-free and low alcohol drinks [02:55]How alcohol-free and low alcohol products are situated in the addiction space [04:40]The methods of the study [06:44]Are alcohol-free and low alcohol drinks more expensive than regular strength drinks across the whole off-trade market? [09:38]Are alcohol-free and low alcohol drinks more expensive than regular strength drinks across comparable products? [10:45]Are price differences associated with pack size and container type and size? [11:52]How Abi would expect the conclusions to change if on-trade sales were included [13:05]Perceptions of the price of alcohol-free and low alcohol drinks in pubs and bars [15:47]The comparison of alcohol-free and low alcohol drinks to soft drinks rather than an alternative to alcohol [17:11]The implications of Abi’s findings for alcohol price policy in the UK [18:00]The take home messages [19:11]About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health. Elle holds a voluntary role at The Loop, a non-profit service provider of drug checking in the UK. About Abi Stevely: Abi is a Research Fellow in the Sheffield Addictions Research Group, where they have worked since 2020. Much of their work to date has focused on evaluating major policy interventions including minimum unit pricing in Scotland. They have also worked on understanding the impact of COVID-19 on drinking behaviour. Abi is currently working on projects evaluating the public health impact of the UK alcohol duty reforms in 2024, the uprating of minimum unit pricing in Scotland to £0.65, and the growing alcohol-free and low-alcohol drinks market.Declarations of interest: None Original article: Are alcohol-free and low-alcohol drinks more expensive than regular-strength drinks? A descriptive analysis of sales data from Great Britain, 2024 https://doi.org/10.1111/add.70568The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr Tsen Vei Lim talks to Dr Martine Skumlien and Professor Valentina Lorenzetti. Martine is a research fellow at King’s College London in the UK and Valentina is a professor at the Australian Catholic University in Australia. The interview covers Martine and Valentina’s research article on brain reward function in young people with cannabis use disorder.The idea that the brain reward system is affected in people with cannabis use disorder [01:28]How our understanding of the neuroscience behind cannabis use disorder affects how we treat cannabis use disorder [03:46]The novel contribution of Martine and Valentina’s study [06:06]How Martine and Valentina investigated the brain reward system in cannabis use disorder [08:18]The key findings from the study [09:24]How we think about the neuroscience of cannabis use disorder [12:33]How do we make sense of the findings alongside the current evidence base [14:33]How the findings sit in the theory of addiction as a brain disease [19:50]The wider implications on future treatment of cannabis use disorder [21:55]About Tsen Vei Lim: Tsen Vei is an academic fellow supported by the Society for the Study of Addiction, currently based at the Department of Psychiatry at the University of Cambridge. His research integrates computational modelling, experimental psychology, and neuroimaging to understand the neuropsychological basis of addictive behaviours. He holds a PhD in Psychiatry from the University of Cambridge (UK) and a BSc in Psychology from the University of Bath (UK). About Martine Skumlien: Martine is a Research Fellow at the King’s College London Social, Genetic & Developmental Psychiatry Centre. Her work focuses on cannabis harm reduction, policy, and impact on the brain. She was previously a research associate in the National Institutes for Health and Care Research (NIHR) Policy Research Unit in Addictions where she conducted research to inform policy within the drug and addictions field, and at the University of Bath where she carried out mixed-methods research into drug checking and detection of novel psychoactive substances. She earned her PhD from the University of Cambridge, investigating how cannabis use influences motivation and reward processing in the brain.About Valentina Lorenzetti: Valentina is a professor, founding Lead of the Neuroscience of Addiction & Mental Health Program, and co-founding Deputy Director of the Healthy Brain and Mind Research Centre at the Australian Catholic University in Melbourne Australia. She also serves as Senior Editor of the journal Addiction. Valentina has dedicated her career to understanding the neurobiology behind how people move into, and out of, addiction and entrenched mental health problems, across Australia, the UK, and Brazil, with a consistent focus on identifying with precision the core neurocircuitry affected and translating that understanding into effective intervention. Valentina’s program combines advanced multimodal neuroimaging, neuromodulation tools, global multi-site cohorts, and novel interventions such as cannabidiol, craving management strategies, and neurofeedback. Tsen Vei, Martine and Valentina have no conflicts of interest to declare.Original article: Brain reward function in young people with cannabis use disorder: A functional magnetic resonance imaging study https://doi.org/10.1111/add.70492 The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.Music provided by Jack Shakespeare. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr Elle Wadsworth talks to Patrick Kelly, a doctoral candidate at Brown University School of Public Health in the US. The interview covers Patrick’s article on clinicians' and people who use drugs' perspectives on artificial intelligence in addiction medicine.What is artificial intelligence and how has artificial intelligence been used in the field of addiction so far [01:18]The importance of knowing the perspectives of clinicians and people who use drugs with regards to artificial intelligence [03:39]What aspects of addiction medicine make it difficult to build artificial intelligence tools [05:34]The setting and sample of Patrick’s study [07:46]Patrick’s first theme drawn out from interviews with clinicians [08:57]Patrick’s second theme drawn out from interviews with clinicians [10:19]Patrick’s third theme drawn out from interviews with clinicians [11:30]Patrick’s fourth theme drawn out from interviews with people who use drugs [12:33]Patrick’s fifth and final theme drawn out from interviews with people who use drugs [13:31]How Patrick would like the findings to contribute to the field [15:11]Being cautiously optimistic about artificial intelligence in addiction medicine [17:39]The next steps [19:35]About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health. Elle holds a voluntary role at The Loop, a non-profit service provider of drug checking in the UK.About Patrick Kelly: Patrick is an addiction scientist, National Institutes of Health (NIH) pre-doctoral fellow, and a PhD Candidate at the Brown University School of Public Health. His research program focuses on measuring multilevel stigma and unregulated drug supply changes using qualitative methods and artificial intelligence tools applied to real-world datasets to design and implement interventions that reduce addiction-related morbidity and mortality.Elle and Patrick have no declarations of interest.Original article: Clinicians' and people who use drugs' perspectives on artificial intelligence in addiction medicine https://doi.org/10.1111/add.70586The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr Tsen Vei Lim talks to Dr Ariel (Ari) Roxburgh. Ari is a Clinical Psychologist and addiction researcher at Monash University and Turning Point, Australia. The interview covers Ari’s review on controlled breathing and heart rate variability biofeedback for drug use-related outcomes.Please note that ‘HRVB’ used in the recording stands for heart rate variability biofeedback.Why Ari and his team explored controlled breathing [01:18]How breathing helps with drug use-related outcomes [02:20]Other breathing techniques examined in Ari’s review [05:03]The key findings from the meta-analysis [05:36]The difference between the examined breathing techniques [07:39]Whether the included studies accounted for the placebo effect [09:52]Whether Ari's findings apply to different drug use disorders [11:45]How soon controlled breathing can be included in clinical guidelines [13:40]How people can incorporate controlled breathing in their daily lives [15:40]The next steps for Ari and his team [17:06]About Tsen Vei Lim: Tsen Vei is an academic fellow supported by the Society for the Study of Addiction, currently based at the Department of Psychiatry at the University of Cambridge. His research integrates computational modelling, experimental psychology, and neuroimaging to understand the neuropsychological basis of addictive behaviours. He holds a PhD in Psychiatry from the University of Cambridge (UK) and a BSc in Psychology from the University of Bath (UK). About Ari Roxburgh: Ari is a Clinical Psychologist and addiction researcher at Monash University and Turning Point. His work focuses on novel substance use interventions, peer-led support frameworks, cognition and psychophysiology. Ari teaches in Monash’s graduate addictive behaviours program, served as convenor for the Australian Psychological Society’s Substance Use Special Interest Group, and regularly consults with government stakeholders on addiction policy.Tsen Vei and Ari have no conflicts of interest to declare.Original article: Controlled breathing and heart rate variability biofeedback for substance use-related outcomes: A systematic review and meta-analysis https://doi.org/10.1111/add.70542The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.Music provided by Jack Shakespeare. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr Tsen Vei Lim talks to Dr Emese Kroon. Emese is a postdoctoral researcher at the Center for Substance Use and Addiction Research at the Erasmus University Rotterdam in the Netherlands. The interview covers Emese’s article on associations of cannabis use with cognitive functioning in individuals with a cannabis use disorder, looking at the moderating role of nicotine.Why nicotine is important when exploring cannabis use disorder [01:29]What we know about the effects of cannabis on the human brain [02:46]What the effects of nicotine are on cognitive function [04:40]The importance of understanding cognitive function in cannabis use disorder [06:05]How Emese addressed the research question [07:16]The key findings from the research [08:56]How do the findings inform how we currently treat cannabis use disorder [13:15]The differences between Emese’s two samples in the study [16:01]Final thoughts from Emese [18:21]About Tsen Vei Lim: Tsen Vei is an academic fellow supported by the Society for the Study of Addiction, currently based at the Department of Psychiatry at the University of Cambridge. His research integrates computational modelling, experimental psychology, and neuroimaging to understand the neuropsychological basis of addictive behaviours. He holds a PhD in Psychiatry from the University of Cambridge (UK) and a BSc in Psychology from the University of Bath (UK). About Emese Kroon: Emese is a postdoctoral researcher at Erasmus University Rotterdam and Aarhus University. Her work bridges neurocognition and socio-cultural context to understand substance use and mental health. She's especially interested in accurate measurement, cross-cultural perspectives, and social influence, and is committed to translating rigorous fundamental science into real-world policy and public dialogue on substance use.Tsen Vei and Emese have no conflicts of interest to declare.Original article: Cross-sectional and longitudinal associations of cannabis use with cognitive functioning in individuals with a cannabis use disorder: The moderating role of nicotine https://doi.org/10.1111/add.70457 The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.Music provided by Jack Shakespeare. Hosted on Acast. See acast.com/privacy for more information.